Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2751 to 2800 of 3761 results for treatment

  1. Early and locally advanced breast cancer: diagnosis and treatment (CG80)

    This guideline has been updated and replaced by NICE guideline NG101.

    Withdrawn guideline

  2. What are the appropriate indications, effectiveness and safety of LDL apheresis in people with heterozygous FH?

    identify a suitable alternative treatment because LDL apheresis is generally only considered in people for whom no other...

    Research recommendation
    Published
    15 November 2019

  3. Stent-graft placement in abdominal aortic aneurysm (HTG106)

    Evidence-based recommendations on stent-graft placement in abdominal aortic aneurysm. This involves patching the weakened section of the aorta with a graft mounted on a stent.

    HealthTech guidance
    Published
    22 March 2006
    View recommendations

    Sections for HTG106

  4. Endovascular closure of atrial septal defect (HTG58)

    Evidence-based recommendations on endovascular closure of atrial septal defect. This involves inserting a small blocking device into the heart, which is gently inflated to close the hole.

    HealthTech guidance
    Published
    27 October 2004
    View recommendations

    Sections for HTG58

  5. Totally endoscopic robotically assisted coronary artery bypass grafting (HTG77)

    Evidence-based recommendations on totally endoscopic robotically assisted coronary artery bypass grafting (TECAB). This involves using small, remote-controlled robotic arms to carry out the grafting procedure.

    HealthTech guidance
    Published
    22 June 2005
    View recommendations

    Sections for HTG77

  6. Ectopic pregnancy and miscarriage (QS69)

    This quality standard covers the diagnosis and initial management of ectopic pregnancy and miscarriage in women in their first trimester (up to 13 completed weeks of pregnancy). It includes assessment and diagnosis for women with suspected early pregnancy loss. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    10 September 2014
    View quality statements

    Sections for QS69

  7. Cardiovascular disease prevention: cholesterol treatment target (secondary prevention) (IND268)

    This indicator has been updated and replaced by NICE indicator 278.

    Withdrawn indicator

  8. The evidence for treating an acute migraine attack is adequate but, for treating subsequent attacks, is limited in quality and quantity. So, for treating acute migraine, this procedure should only be used with special arrangements for clinical governance, consent, and audit or research. Find out what special arrangements mean on the NICE interventional procedures guidance page . The evidence for preventing migraine is inadequate in quality. So, for preventing migraine, this procedure should only be used in the context of research. Find out what only in research means on the NICE interventional procedures guidance page.

    transcutaneous electrical stimulation of the supraorbital nerve for acute treatment of migraine should: Inform the clinical governance...

    Research recommendation
    Published
    7 November 2022

  9. Interim process and methods guide for the clinical guideline updates using standing committees pilot programme 2013 (PMG17)

    This guide outlines the main elements of the interim process and methods for the NICE clinical guideline updates using standing committees pilot programme, including details of the Clinical Guidelines Updates committee, which were agreed by the NICE Board in September 2013

  10. Automated blood pressure monitoring in people with atrial fibrillation: Which automated blood pressure monitors are suitable for people with hypertension and atrial fibrillation?

    made the recommendation for research, see the rationale on monitoring treatment and blood pressure targets for people without...

    Research recommendation
    Published
    11 April 2022

  11. What are the long-term effects of statin therapy on sub-clinical atherosclerosis in children with FH who are treated with statin therapy?

    adverse effects of statin treatment in a population with FH, as people generally take statins for the rest of their lives once...

    Research recommendation
    Published
    15 November 2019

  12. Laparoscopic surgery for inguinal hernia repair (TA83)

    Evidence-based recommendations on laparoscopic surgery for treating inguinal hernia.

    Technology appraisal guidance
    Published
    22 September 2004
    View recommendations

    Sections for TA83

  13. Neoadjuvant therapy:- Prospective randomised trials should be undertaken to compare preoperative (neoadjuvant) therapy with standard postoperative therapy in people with resectable pancreatic cancer.

    benefit of neoadjuvant therapy.Research is needed to compare neoadjuvant treatments (which might be chemotherapy, radiotherapy or both)...

    Research recommendation
    Published
    13 November 2018

  14. Interim methods guide for developing service guidance 2014 (PMG8)

    This manual provides information additional to that in Developing NICE guidelines: the manual to guide developers on how to approach developing service guidance, and also to inform stakeholders about the steps that NICE will take in developing this guidance

  15. In moderate- to high-severity community-acquired pneumonia does using legionella and pneumococcal urinary antigen testing in addition to other routine tests improve outcomes?

    has looked at using urinary antigen testing to target treatment. If effective, such targeted treatment could improve...

    Research recommendation
    Published
    9 June 2015

  16. Inhaled corticosteroid responsiveness:- What features predict inhaled corticosteroid responsiveness most accurately in people with COPD?

    important:- Bronchodilators and/or steroids are the main pharmacological treatments used to manage COPD. People with asthma or asthmatic...

    Research recommendation
    Published
    6 February 2019

  17. Online help programme recommended for people with eating disorders

    An online therapy programme can be used to help people aged 16 and over with eating disorders whilst they wait for specialist NHS treatment, an independent NICE has said.

    News
    Last updated
    22 January 2026

  18. Jejunostomy support after radical surgery:- What is the effectiveness of long-term jejunostomy support compared to intensive dietary counselling and support along with symptom management for people having radical surgery for oesophago-gastric cancer?

    patients have adjuvant treatment, however their nutritional status may negatively impact on their ability to tolerate this, meaning...

    Research recommendation
    Published
    13 November 2018

  19. Combined bronchodilator and corticosteroid therapy for bronchiolitis:- What is the efficacy of combined bronchodilator and corticosteroid therapy?

    applicable) Why this is important:- There are no effective therapies for the treatment of bronchiolitis. One study reported that infants...

    Research recommendation
    Published
    6 October 2015

  20. Subcutaneous methotrexate:- What is the clinical and cost effectiveness of subcutaneous methotrexate compared with oral methotrexate for adults with early onset RA starting a new DMARD?

    important drug in the treatment of RA. Subcutaneous administration is an alternative option for people who have side effects with oral...

    Research recommendation
    Published
    11 December 2018

  21. The SpyGlass direct visualisation system for diagnostic and therapeutic procedures during endoscopy of the biliary system (MIB21)

    NICE has developed a Medtech Innovation Briefing (MIB) on the SpyGlass direct visualisation system for diagnostic and therapeutic procedures during endoscopy of

    Medtech innovation briefing
    Published
    12 February 2015

  22. Non-rigid stabilisation techniques for the treatment of low back pain (IPG366)

    Interventional procedures, IPG366 - Issued: November 2010 --> We have moved interventional procedures guidance 366 to become HealthTech guidance 239. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  23. Non-rigid stabilisation techniques for the treatment of low back pain (IPG183)

    This guidance has been updated and replaced by NICE HealthTech guidance 239.

    Withdrawn guidance

  24. Radiofrequency ablation for the treatment of colorectal metastases in the liver (IPG92)

    This guidance has been updated and replaced by NICE HealthTech guidance 208.

    Withdrawn guidance

  25. Beta interferon and glatiramer acetate for the treatment of multiple sclerosis (TA32)

    This guidance has been updated and replaced by NICE technology appraisal guidance 527.

    Withdrawn guidance

  26. Lactate level for monitoring severity of shock:- Is lactate monitoring in patients with major trauma clinically and cost effective?

    notes(if applicable) Why this is important:- In current practice, treatment for hypovolaemic shock is guided by the patient's...

    Research recommendation
    Published
    21 March 2016

  27. What is the clinical and cost effectiveness of antibiotics for the management of acute diverticulitis in primary care?

    the person should be reassessed if necessary and the need for antibiotic treatment should be reviewed. The need for intravenous...

    Research recommendation
    Published
    10 February 2020

  28. Further research is recommended to help address remaining clinical and cost-effectiveness uncertainties for esketamine, summarised in section 3.36 .

    assessment and decision modelling • the natural history and long-term course of treatment-resistant depression and health-related...

    Research recommendation
    Published
    6 January 2023

  29. Methylphenidate for the treatment of attention deficit hyperactivity disorder in children and adolescents (TA13)

    This guidance has been replaced by NICE technology appraisal guidance 98 [Replaced by NICE guideline NG87].  

    Withdrawn guidance

  30. Lifelight First for monitoring vital signs (MIB213)

    NICE has developed a medtech innovation briefing (MIB) on Lifelight First for monitoring vital signs .

    Medtech innovation briefing
    Published
    8 April 2020

  31. Healthy.io test for home testing of urine albumin to creatinine ratio (MIB221)

    NICE has developed a medtech innovation briefing (MIB) on Healthy.io test for home testing of urine albumin to creatinine ratio .

    Medtech innovation briefing
    Published
    11 August 2020

  32. Ambulight PDT for the treatment of non-melanoma skin cancer (MTG6)

    We have moved medical technologies guidance 6 to become HealthTech guidance 268. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  33. PredictSURE IBD and IBDX to guide treatment of Crohn's disease (DG45)

    We have moved Diagnostics guidance 45 to become HealthTech guidance 610. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  34. Bevacizumab for the first-line treatment of metastatic breast cancer (TA147)

    This appraisal has been updated and replaced by NICE technology appraisal 214.

    Withdrawn guidance

  35. Erlotinib for the treatment of non-small-cell lung cancer (TA162)

    This guidance has been updated and replaced by NICE technology appraisal guidance 374.

    Withdrawn guidance

  36. Cetuximab for the first-line treatment of metastatic colorectal cancer (TA176)

    This guidance has been updated and replaced by NICE technology appraisal guidance 439.

    Withdrawn guidance

  37. Telaprevir for the treatment of genotype 1 chronic hepatitis C (TA252)

    Telaprevir no longer has a marketing authorisation in the UK so this guidance has been withdrawn.

    Withdrawn guidance

  38. Human growth hormone for the treatment growth failure in children (TA42)

    This guidance has been updated and replaced by NICE technology appraisal guidance 188. 

    Withdrawn guidance

  39. What is the clinical and cost effectiveness of levothyroxine (T4) and liothyronine (T3) combination therapy compared with T4 alone for people with hypothyroidism whose symptoms have not responded sufficiently to T4 alone? Does DiO2 polymorphism affect the response to combination therapy with T4 and T3?

    agreed that hypothyroidism needs thyroid hormone replacement. Potential treatments are levothyroxine, usually prescribed to everyone,...

    Research recommendation
    Published
    10 February 2020

  40. Comprehensive assessment versus a brief assessment:- For people with a suspected common mental health disorder, what is the clinical and cost effectiveness of using a comprehensive assessment (conducted by mental health professional) versus a brief assessment (conducted by a paraprofessional)?

    remains about the accuracy and consequent identification of appropriate treatment by paraprofessionals in primary care. An assessment by...

    Research recommendation
    Published
    9 June 2015

  41. Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza (TA158)

    Evidence-based recommendations on oseltamivir (Tamiflu), amantadine (Lysovir or Symmetrel) or zanamivir (Relenza) to prevent influenza (flu).

    Technology appraisal guidance
    Published
    24 September 2008
    View recommendations

    Sections for TA158

  42. SecurAcath for securing cerebrospinal fluid catheters (MIB107)

    NICE has developed a medtech innovation briefing (MIB) on SecurAcath for securing cerebrospinal fluid catheters .

    Medtech innovation briefing
    Published
    5 June 2017

  43. Interim methods guide for developing good practice guidance (PMG15)

    This interim methods guide is based on the general principles and methods included in other methods guides for developing NICE guidance

  44. Xpert Carba-R to identify people carrying carbapenemase-producing organisms (MIB52)

    NICE has developed a medtech innovation briefing (MIB) on the Xpert Carba-R to identify people carrying carbapenemase-producing organisms

    Medtech innovation briefing
    Published
    12 February 2016

  45. Suspected cancer (QS124)

    This quality standard covers the investigation and recognition of suspected cancer, and referral to specialist cancer services for adults, young people and children. It describes high-quality care in priority areas for improvement.

    Quality standard
    Last updated
    5 December 2017
    View quality statements

    Sections for QS124

  46. Care pathway:- In the UK, what is the optimal care pathway for young people and adults with coexisting severe mental illness and substance misuse?

    important:- There is a lack of published evidence on care pathways on treatment, management and follow-up of people with coexisting...

    Research recommendation
    Published
    10 February 2017

  47. NICE encourages further research on laparoscopic gastric plication for severe obesity, which should include information about long-term efficacy and safety, and specifically how the procedure influences further gastric surgery. Comparison with alternative procedures would be useful.

    efficacy of the procedure. Therefore, laparoscopic gastric plication for the treatment of severe obesity should only be used with...

    Research recommendation
    Published
    9 June 2015

  48. Epidurals:- What is the clinical and cost effectiveness of image-guided compared with non-image-guided epidural injections for people with acute sciatica?

    notes(if applicable) Why this is important:- Epidural injection of treatments, including corticosteroids, is commonly offered to people...

    Research recommendation
    Published
    13 February 2017

  49. Computerised cognitive behaviour therapy (CCBT) for the treatment of depression and anxiety (TA51)

    This guidance has been updated and replaced by NICE technology appraisal guidance 97.

    Withdrawn guidance

  50. Prasugrel for the treatment of acute coronary syndromes with percutaneous coronary intervention (TA182)

    This guidance has been replaced by NICE technology appraisal guidance 317.

    Withdrawn guidance